The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact
Open accessPreprint — published as 10.1016/j.eclinm.2021.101019 · Paper page
Abstract
Growing evidence shows that a significant number of patients with COVID-19 experience prolonged symptoms, known as Long COVID. Few systematic studies exist which investigate this population, and hence, relatively little is known about the range in symptom makeup and severity, expected clinical course, impact on daily functioning, and expected return to baseline health. In this study, we analysed responses from 3,762 participants with confirmed (diagnostic/antibody positive; 1,020) or suspected (diagnostic/antibody negative or untested; 2,742) COVID-19, from 56 countries, with illness duration of at least 28 days. 3608 (96%) reported symptoms beyond 90 days. Prevalence of 205 symptoms in 10 organ systems was estimated in this cohort, with 66 symptoms traced over seven months. Except for loss of smell and taste, the prevalence and trajectory of all symptoms were similar between groups with confirmed and suspected COVID-19. Respondents experienced an average of 14.5 symptoms in an average of 9.08 organ systems. Three clusters of symptoms were identified based on their prevalence over time. The most likely early symptoms were fatigue, dry cough, shortness of breath, headaches, muscle aches, chest tightness, and sore throat. The most frequent symptoms reported after month 6 were fatigue, post-exertional malaise, and cognitive dysfunction. Majority (>85%) experienced relapses, with exercise, physical or mental activity, and stress as the main triggers. 1,700 (45.2%) reported requiring a reduced work schedule compared to pre-illness and 839 (22.3%) were not working at the time of survey due to their health conditions. Significance Statement: Results from our international online survey of 3,762 individuals with suspected or confirmed COVID-19 illness suggest that Long COVID is composed of heterogeneous post-acute infection sequelae that often affect multiple organ systems, with impact on functioning and quality of life ranging from mild to severe. This study represents the largest collection of symptoms identified in the Long COVID population to date, and is the first to quantify individual symptom trajectory over time, for 7 months. Three clusters of symptoms were quantified, each with different morphologies over time. The clusters of symptoms that persist longest include a combination of the neurological/cognitive and systemic symptoms. The reduced work capacity because of cognitive dysfunction, in addition to other debilitating symptoms, translated into the loss of hours, jobs, and ability to work relative to pre-illness levels. Structured Abstract: Objective: To characterize the symptom profile and time course in patients with Long COVID, along with the impact on daily life, work, and return to baseline health. Design: International web-based survey of suspected and confirmed COVID-19 cases with illness lasting over 28 days and onset prior to June 2020. Setting: Survey distribution via online COVID-19 support groups and social media Participants: 3,762 respondents from 56 countries completed the survey. 1166 (31.0%) were 40-49 years old, 937 (25.0%) were 50-59 years old, 905 (24.1%) were 30-39 years old, 277 (7.4%) were 18-29 years old, and 477 (12.7%) were above 60 years old. 2961 (78.9%) were women, 718 (19.1%) were men, and 63 (1.7%) were nonbinary. 317 (8.4%) reported being hospitalized. 1020 (27.1%) reported receiving a laboratory-confirmed diagnosis of COVID-19. 3608 (96%) reported symptoms beyond 90 days. Results: Prevalence of 205 symptoms in 10 organ systems was estimated in this cohort, with 66 symptoms traced over seven months. Except for loss of smell and taste, the prevalence and trajectory of all other symptoms are similar between confirmed (diagnostic/antibody positive) and suspected groups (diagnostic/antibody negative or untested). Respondents experienced symptoms in an average of 9.08 (95% confidence interval 9.04 to 9.13) organ systems. The most frequent symptoms reported after month 6 were: fatigue (77.7%, 74.9% to 80.3%), post-exertional malaise (72.2%, 69.3% to 75.0%), and cognitive dysfunction (55.4%, 52.4% to 58.8%). These three symptoms were also the three most commonly reported overall. In those who recovered in less than 90 days, the average number of symptoms peaked at week 2 (11.4, 9.4 to 13.6), and in those who did not recover in 90 days, the average number of symptoms peaked at month 2 (17.2, 16.5 to 17.8). Respondents with symptoms over 6 months experienced an average of 13.8 (12.7 to 14.9) symptoms in month 7. 85.9% (84.8% to 87.0%) experienced relapses, with exercise, physical or mental activity, and stress as the main triggers. 86.7% (85.6% to 92.5%) of unrecovered respondents were experiencing fatigue at the time of survey, compared to 44.7% (38.5% to 50.5%) of recovered respondents. 45.2% (42.9% to 47.2%) reported requiring a reduced work schedule compared to pre-illness and 22.3% (20.5% to 24.3%) were not working at the time of survey due to their health conditions. Conclusions: Patients with Long COVID report prolonged multisystem involvement and significant disability. Most had not returned to previous levels of work by 6 months. Many patients are not recovered by 7 months, and continue to experience significant symptom burden.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Using thematic analysis in psychology
Braun, V., & Clarke, V. (2006) · Qualitative Research in Psychology · doi:10.1191/1478088706qp063oa · Cited by 194,414
Persistent Symptoms in Patients After Acute COVID-19
Carfì, A., Bernabei, R., Landi, F., & for the Gemelli Against COVID-19 Post-Acute Care Study Group (2020) · JAMA · doi:10.1001/jama.2020.12603 · Cited by 4,561
Attributes and predictors of long COVID
Sudre, C. H., Murray, B., Varsavsky, T., Graham, M. S., Penfold, R. S., Bowyer, R. C., Pujol, J. C., Klaser, K., Antonelli, M., Canas, L. S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01292-y · Cited by 2,707
Bootstrap confidence intervals
DiCiccio, T. J., & Efron, B. (1996) · Statistical Science · doi:10.1214/ss/1032280214 · Cited by 2,286
Management of post-acute covid-19 in primary care
Greenhalgh, T., Knight, M., A’Court, C., Buxton, M., & Husain, L. (2020) · BMJ · doi:10.1136/bmj.m3026 · Cited by 1,689
Evolution of antibody immunity to SARS-CoV-2
Gaebler, C., Wang, Z., Lorenzi, J. C. C., Muecksch, F., Finkin, S., Tokuyama, M., Cho, A., Jankovic, M., Schaefer-Babajew, D., Oliveira, T. Y., et al. (2021) · Nature · doi:10.1038/s41586-021-03207-w · Cited by 1,674
Kucirka, L. M., Lauer, S. A., Laeyendecker, O., Boon, D., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-1495 · Cited by 1,414
Tenforde, M. W., Kim, S. S., Lindsell, C. J., Billig Rose, E., Shapiro, N. I., Files, D. C., Gibbs, K. W., Erickson, H. L., Steingrub, J. S., Smithline, H. A., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6930e1 · Cited by 1,319
Concept Decompositions for Large Sparse Text Data Using Clustering
Dhillon, I. S., & Modha, D. S. (2001) · Machine Learning · doi:10.1023/a:1007612920971 · Cited by 1,293
Survival Analysis: A Self-Learning Text
Kleinbaum, D. G., & Klein, M. (2012) · Statistics for Biology and Health · doi:10.1007/978-1-4419-6646-9 · Cited by 1,015
Characterising long COVID: a living systematic review
Michelen, M., Manoharan, L., Elkheir, N., Cheng, V., Dagens, A., Hastie, C., O'Hara, M., Suett, J., Dahmash, D., Bugaeva, P., et al. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2021-005427 · Cited by 960
How and why patients made Long Covid
Callard, F., & Perego, E. (2021) · Social Science & Medicine · doi:10.1016/j.socscimed.2020.113426 · Cited by 924
Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?
Goërtz, Y. M. J., Van Herck, M., Delbressine, J. M., Vaes, A. W., Meys, R., Machado, F. V. C., Houben-Wilke, S., Burtin, C., Posthuma, R., Franssen, F. M. E., et al. (2020) · ERJ Open Research · doi:10.1183/23120541.00542-2020 · Cited by 847
Interpreting a covid-19 test result
Watson, J., Whiting, P. F., & Brush, J. E. (2020) · BMJ · doi:10.1136/bmj.m1808 · Cited by 712
Cognitive deficits in people who have recovered from COVID-19
Hampshire, A., Trender, W., Chamberlain, S. R., Jolly, A. E., Grant, J. E., Patrick, F., Mazibuko, N., Williams, S. C., Barnby, J. M., Hellyer, P., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101044 · Cited by 701
Better Bootstrap Confidence Intervals
Efron, B. (1987) · Journal of the American Statistical Association · doi:10.2307/2289144 · Cited by 698
Arnold, D. T., Hamilton, F. W., Milne, A., Morley, A. J., Viner, J., Attwood, M., Noel, A., Gunning, S., Hatrick, J., Hamilton, S., et al. (2021) · Thorax · doi:10.1136/thoraxjnl-2020-216086 · Cited by 627
Detection of Novel Coronavirus by RT-PCR in Stool Specimen from Asymptomatic Child, China
Tang, A., Tong, Z.-D., Wang, H.-L., Dai, Y.-X., Li, K.-F., Liu, J.-N., Wu, W.-J., Yuan, C., Yu, M.-L., Li, P., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2606.200301 · Cited by 516
Measuring fatigue in sarcoidosis: The Fatigue Assessment Scale (FAS)
de Vries, J., Michielsen, H., Van Heck, G. L., & Drent, M. (2004) · British Journal of Health Psychology · doi:10.1348/1359107041557048 · Cited by 424
Long COVID in the Faroe Islands: A Longitudinal Study Among Nonhospitalized Patients
Petersen, M. S., Kristiansen, M. F., Hanusson, K. D., Danielsen, M. E., á Steig, B., Gaini, S., Strøm, M., & Weihe, P. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1792 · Cited by 365
Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome
Afrin, L. B., Weinstock, L. B., & Molderings, G. J. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.09.016 · Cited by 314
FALSE-NEGATIVE RESULTS OF INITIAL RT-PCR ASSAYS FOR COVID-19: A SYSTEMATIC REVIEW
Arevalo-Rodriguez, I., Buitrago-Garcia, D., Simancas-Racines, D., Zambrano-Achig, P., Campo, R. D., Ciapponi, A., Sued, O., Martínez-García, L., Rutjes, A., Low, N., et al. (2020) · medRxiv · doi:10.1101/2020.04.16.20066787 · Cited by 310
COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors
Mitrani, R. D., Dabas, N., & Goldberger, J. J. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.06.026 · Cited by 302
Diagnostic Testing for the Novel Coronavirus
Sharfstein, J. M., Becker, S. J., & Mello, M. M. (2020) · JAMA · doi:10.1001/jama.2020.3864 · Cited by 230
Stussman, B., Williams, A., Snow, J., Gavin, A., Scott, R., Nath, A., & Walitt, B. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.01025 · Cited by 164
Analytical comparisons of SARS-COV-2 detection by qRT-PCR and ddPCR with multiple primer/probe sets
Liu, X., Feng, J., Zhang, Q., Guo, D., Zhang, L., Suo, T., Hu, W., Guo, M., Wang, X., Huang, Z., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1772679 · Cited by 158
SARS-CoV-2 detection in different respiratory sites: A systematic review and meta-analysis
Mohammadi, A., Esmaeilzadeh, E., Li, Y., Bosch, R. J., & Li, J. Z. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102903 · Cited by 148
Postural orthostatic tachycardia syndrome
Agarwal, A., Garg, R., Ritch, A., & Sarkar, P. (2007) · Postgraduate Medical Journal · doi:10.1136/pgmj.2006.055046 · Cited by 136
Survival Analysis - A Self-Learning Text Third Edition
Puyneers, P. (2012) · Cited by 95
Surveillance is underestimating the burden of the COVID-19 pandemic
Alwan, N. A. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31823-7 · Cited by 92
Salmon, D., Slama, D., de Broucker, T., Karmochkine, M., Pavie, J., Sorbets, E., Etienne, N., Batisse, D., Spiridon, G., Baut, V. L., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.12.002 · Cited by 91
Care Dependency in Non-Hospitalized Patients with COVID-19
Vaes, A. W., Machado, F. V. C., Meys, R., Delbressine, J. M., Goërtz, Y. M. J., Herck, M. V., Houben‐Wilke, S., Franssen, F. M. E., Vijlbrief, H., Spies, Y., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092946 · Cited by 88
Coronavirus disease-2019: is fever an adequate screening for the returning travelers?
Bwire, G. M., & Paulo, L. S. (2020) · Tropical Medicine and Health · doi:10.1186/s41182-020-00201-2 · Cited by 83
Disability Accommodation in Nonstandard and Precarious Employment Arrangements
Shuey, K. M., & Jovic, E. (2013) · Work and Occupations · doi:10.1177/0730888413481030 · Cited by 81
Temperature screening has negligible value for control of COVID ‐19
Mitra, B., Lückhoff, C., Mitchell, R. D., O’Reilly, G. M., Smit, D. V., & Cameron, P. A. (2020) · Emergency Medicine Australasia · doi:10.1111/1742-6723.13578 · Cited by 47
Neurologic manifestations of nonhospitalized patients with COVID‐19 in Wuhan, China
Ding, H., Yin, S., Cheng, Y., Cai, Y., Huang, W., & Deng, W. (2020) · MedComm · doi:10.1002/mco2.13 · Cited by 44
TABACOF, L. R., Tosto-Mancuso, J., Wood, J., Cortes, M., Kontorovich, A., McCarthy, D., Rizk, D., Mohammadi, N., Breyman, E., Nasr, L., et al. (2020) · medRxiv · doi:10.1101/2020.11.04.20226126 · Cited by 41
Body temperature screening to identify SARS-CoV-2 infected young adult travellers is ineffective
Bielecki, M., Crameri, G. A. G., Schlagenhauf, P., Buehrer, T. W., & Deuel, J. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101832 · Cited by 33
Fatigue Assessment Scale (FAS)
Shahid, A., Wilkinson, K., Marcu, S., & Shapiro, C. M. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9893-4_33 · Cited by 28
Anjum, I., Sohail, W., Hatipoğlu, B., & Wilson, R. (2018) · Cureus · doi:10.7759/cureus.2435 · Cited by 13
Health Workers’ Antibody Levels Wane After SARS-CoV-2 Infection
Kuehn, B. M. (2021) · JAMA · doi:10.1001/jama.2020.25457 · Cited by 8
Cited by
Long-term cardiovascular outcomes of COVID-19
Xie, Y., Xu, E., Bowe, B., & Al-Aly, Z. (2022) · Nature Medicine · doi:10.1038/s41591-022-01689-3 · Cited by 2,029
Long covid—mechanisms, risk factors, and management
Crook, H., Raza, S., Nowell, J., Young, M., & Edison, P. (2021) · BMJ · doi:10.1136/bmj.n1648 · Cited by 1,655
Fatigue and cognitive impairment in Post-COVID-19 Syndrome: a systematic review and meta-analysis
Ceban, F., Ling, S., Lui, L. M. W., Lee, Y., Gill, H., Teopiz, K. M., Rodrigues, N. B., Subramaniapillai, M., Di Vincenzo, J. D., Cao, B., et al. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.12.020 · Cited by 1,554
Chen, C., Haupert, S. R., Zimmermann, L., Shi, X., Fritsche, L. G., & Mukherjee, B. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac136 · Cited by 1,366
Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
Yong, S. J. (2021) · Infectious Diseases · doi:10.1080/23744235.2021.1924397 · Cited by 1,339
Metadata
- Authors
- Davis, H. E., Assaf, G. S., McCorkell, L., Wei, H., Low, R. J., Re’em, Y., Redfield, S., Austin, J. P., & Akrami, A.
- Venue
- medRxiv
- Publisher
- openRxiv
- Published
- 2020-12-26
- OpenAlex
- W3115058895
- Cited by
- 387
- References
- 41
- Type
- posted content
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.